Cargando…

Effect of baseline serum vitamin D level on symptom and medication scores of subcutaneous immunotherapy in children with mite allergy

INTRODUCTION: Allergen immunotherapy (AIT) is considered to be the only treatment that may change the natural process of allergic diseases. Subcutaneous immunotherapy (SCIT) is a type of allergen immunotherapy that is commonly used in clinical practice. However, SCIT has inconsistent effects on indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Xiaoxiao, Zheng, Hang, Yan, Xiumei, Dai, Huan, Xiang, Qiangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663479/ https://www.ncbi.nlm.nih.gov/pubmed/36389357 http://dx.doi.org/10.3389/fped.2022.1018549

Ejemplares similares

High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
por: Fritszching, Benedikt, et al.
Publicado: (2023)

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
por: Zheng, Chen, et al.
Publicado: (2023)

Vitamin D Role in Childhood Mite Allergy and Allergen Immunotherapy (AIT)
por: Petrarca, Claudia, et al.
Publicado: (2023)

Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Sublingual immunotherapy for pediatric patients with mite allergies
por: Kajiume, Teruyuki
Publicado: (2022)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Retrospective evaluation of adverse reactions after subcutaneous allergen-specific immunotherapy in children with house dust mite allergy
por: Altas, Ugur, et al.
Publicado: (2023)

Effectiveness of sublingual immunotherapy with house dust mite drops in asthmatic children at different ages
por: Ai, Tao, et al.
Publicado: (2023)

Role of Vitamin D in Prevention of Food Allergy in Infants
por: Giannetti, Arianna, et al.
Publicado: (2020)

Oral Immunotherapy in Food Allergy: A Critical Pediatric Perspective
por: Akarsu, Aysegul, et al.
Publicado: (2022)

New approaches to immunotherapy in house dust mite allergy
por: Kim, In Sik
Publicado: (2022)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

Study on Intestinal Flora and Asthma: Knowledge Graph Analysis Based on CiteSpace (2001–2021)
por: Zheng, Hang, et al.
Publicado: (2023)

Relationship of Allergy with Asthma: There Are More Than the Allergy “Eggs” in the Asthma “Basket”
por: Guibas, George V., et al.
Publicado: (2017)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021)

House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
por: Nogami, Kazutaka, et al.
Publicado: (2022)

A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies
por: Lee, Sang Pyo, et al.
Publicado: (2017)

The PATHOGENesis of Food Allergy
por: Ong, Peck Y.
Publicado: (2019)

Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome
por: Kong, Nasil, et al.
Publicado: (2019)

Circulating C-X-C Motif Ligand 13 as a Biomarker for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With Chronic Allergic Rhinitis
por: Cheng, Shenghao, et al.
Publicado: (2022)

Effects of Serum Vitamin D and Efficacy of Subcutaneous Immunotherapy in Adult Patients With Allergic Rhinitis
por: Joudi, Maryam, et al.
Publicado: (2019)

Expression of Vitamin D Receptor Pathway Genes in Subcutaneous Adipose Tissue of Obese Individuals
por: Ginnard, Olivia Z B, et al.
Publicado: (2021)

Exercise-Induced Bronchospasm and Allergy
por: Caggiano, Serena, et al.
Publicado: (2017)

Probiotics in Asthma and Allergy Prevention
por: Mennini, Maurizio, et al.
Publicado: (2017)

Regulatory T Cells in Allergy and Asthma
por: Martín-Orozco, Elena, et al.
Publicado: (2017)

A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy
por: Roger, Albert, et al.
Publicado: (2014)

Systemic Reactions to Dust Mite Subcutaneous Immunotherapy: A 3-Year Follow-up Study
por: Dong, Xiang, et al.
Publicado: (2016)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy
por: Zheng, Peiyan, et al.
Publicado: (2021)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)

Total serum IgE levels as predictor of the acquisition of tolerance in children with food allergy: Findings from a pilot study
por: Dodi, Giulia, et al.
Publicado: (2022)

Molecular Diagnosis of Allergy: The Pediatric Perspective
por: Dramburg, Stephanie, et al.
Publicado: (2019)

Neurologic manifestations in anaphylaxis due to subcutaneous allergy immunotherapy: A case report
por: Mangold, Michelle, et al.
Publicado: (2018)

Evaluation of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome
por: Hamada, Masaaki, et al.
Publicado: (2021)

Establishment and characterization of murine models of asthma and subcutaneous immunotherapy for Humulus pollen allergy
por: Xi, Guang P., et al.
Publicado: (2021)

Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust
por: Lim, Fang Lee, et al.
Publicado: (2015)

Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
por: Kim, Myoung-Eun, et al.
Publicado: (2011)

Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
por: Rattanamanee, Tipyapa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1sac6v36l10ob1gefqon9fsi50